欧洲队列中早产相关支气管肺发育不良患病率单位间差异的影响因素
该研究基于EPICE前瞻性人群队列,纳入11个欧洲国家19个地区83个新生儿病房的5,285名<32周极早产儿,分析病房层面因素对中/重度支气管肺发育不良(BPD)患病率差异的影响。未调整BPD患病率范围为2%-47%(中位数13%),标准化后为8%-42%(中位数17%);氧饱和度目标、初始机械通气比例和产后糖皮质激素使用部分解释了病房间差异(方差比例变化分别为25%、5%、17%),53%的差异未被解释。
要点
- 欧洲新生儿病房间极早产儿BPD患病率差异显著,未调整范围2%-47%。
- 氧饱和度目标、初始机械通气比例和产后激素使用部分解释病房间差异。
- 改善极早产儿呼吸管理可能有助于降低BPD患病率。
核心结论
- 欧洲新生儿病房间极早产儿BPD患病率存在大幅变异,仅部分由患者特征解释。
- 改善极早产儿呼吸管理可能有益于降低BPD患病率。
- 病房产后糖皮质激素使用实践与BPD的关联需进一步研究。
研究设计与样本
- 基于EPICE前瞻性人群队列,覆盖11个欧洲国家19个地区。
- 纳入83个年极早产儿收治≥40例的新生儿病房,共5,285名<32周极早产儿,排除严重先天畸形。
- 采用标准化患病率、Spearman相关和多水平logistic回归分析病房层面因素与BPD的关联。
主要发现
- 未调整中/重度BPD患病率范围为2%-47%(中位数13%),标准化后为8%-42%(中位数17%)。
- 氧饱和度目标、初始机械通气比例和产后糖皮质激素使用对病房间方差的比例变化分别为25%、5%和17%,剩余53%未解释。
- 风险调整后院内死亡率(范围8%-21%)和患者收治量与BPD患病率无相关性。
临床怎么用
- 关注病房氧饱和度目标、初始机械通气策略和产后糖皮质激素使用实践对BPD患病率的影响。
- 病房间BPD患病率差异大部分未被解释,需进一步研究其他病房层面因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Bronchopulmonary dysplasia (BPD) is the most common morbidity of very preterm (VPT) infants born < 32 weeks' gestation with lifelong consequences. Studies document wide variation between regions and units in BPD prevalence. RESEARCH QUESTION: Which unit-level factors contribute to the variation in BPD prevalence among VPT infants in European neonatal units? STUDY DESIGN AND METHODS: Analyses were conducted using the prospective population-based Effective Perinatal Intensive Care in Europe (EPICE) cohort in 19 regions in 11 European countries. We compared prevalence of moderate/severe BPD among VPT infants without severe congenital anomalies in neonatal units with ≥ 40 annual VPT admissions (83 units and 5,285 infants). Unit prevalence was adjusted for individual risk factors using standardized morbidity rates. Spearman correlation and multilevel logistic regression were used to assess associations of BPD with unit-level variables: unit mortality rates, first week oxygen saturation targets, proportion of infants ventilated within the first 24 hours, unit practice of postnatal corticosteroid use for hypotension or BPD prevention, and unit volume. RESULTS: Unadjusted BPD prevalence ranged from 2% to 47% (median, 13%) between units and was 8% to 42% (median, 17%) after adjustment and standardization. Oxygen saturation targets, proportion of initial mechanical ventilation, and postnatal corticosteroid use partly explained the between-unit variability (proportional change of variance: 25%, 5%, and 17%, respectively), leaving 53% unexplained. Risk-adjusted in-hospital mortality (range, 8%-21%) and patient volume were not correlated with BPD prevalence. INTERPRETATION: Our results show that large variability in BPD prevalence exists between European units, which was only partially explained by patient characteristics. Our findings suggest that improving respiratory management for VPT infants could be beneficial for reducing BPD prevalence. The association of unit postnatal corticosteroid use practice with BPD requires further investigation.
引用
- Staude B, Torchin H, Maier RF, et al. Factors Influencing Unit-Level Differences in Prevalence of Prematurity-Associated Bronchopulmonary Dysplasia in a European Cohort: An Observational Study. Chest. 2025. PMID: 41391582. doi:10.1016/j.chest.2025.11.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。